Aminoacids and derivatives

<p>Applications 2,5-Piperazinedione, can be used as an intermediate in the preparation of various pharmaceutical and biologically active compounds. It can be used in the synthesis of dipeptide isosteres by cross-metathesis.<br>References Enholm, J.E. et al.: Tetrahedron, 68, 6920 (2012);<br></p>

<p>Applications A metabolite of 5-Hydroxytryptamine, also known as Serotonin (S274990).<br>References Uutela, P. et al.: Anal. Chem., 81, 8417 (2009); Koehle, C. et al.: Biochem. Pharmacol., 69, 1397 (2005); Krishnaswamy, S. et al.: Xenobiotica, 33, 169 (2003);<br></p>

<p>Applications ε-​Caprolactam is a synthetic precursor of Nylon-6 and other synthetic polymers. This compound also inhibits the growth of several Bacillus and Rhizobium species, but Arthrobacter species grow normally in the presence of this compound.<br>References Bomfim, Marcus V.J., et al.: Braz. J. Pharm. Sci., 45(1), 21-35 (2009); Kalinova, Jana P., et al.: Food Chem., 157, 380-384 (2014)<br></p>

<p>Applications α-Methyldopa Methyl Ester is an impurity in the synthesis of L-α-Methyl DOPA Methyl Ester Hydrochloride which is a Methyldopa angiotensin II analog.<br>References Karle, I., et al.: Biochemistry, 29, 6747 (1990), Biron, E., et al.: Bioorg. Med. Chem., 12, 1279 (2004),<br></p>

<p>Applications Lacosamide is a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lees, G., et al.: Brain Res., 612, 190 (1993), Kuo, C., et al.: Mol. Pharmacol., 51, 1077 (1997), Barton, M., et al.: Epilepsy Res., 47, 217 (2001), Beyreuther, B., et al.: Eur. J. Pharmacol., 539, 64 (2006), Beyreuther, B., et al.: CNS Drug Rev., 13, 21 (2007),<br></p>

<p>Stability Hygroscopic<br>Applications (R)-2-Amino-N-benzyl-3-methoxypropionamide is an impurity of Lacosamide which is a potent anticonvulsant.<br>References Letiran, A., et al.: J. Med. Chem., 45, 4762 (2002); Wadavrao, S., et al.: Synthesis, 45, 3383 (2013)<br></p>

<p>Stability Hygroscopic<br>Applications Spermidine is a biogenic polyamine formed from putrescine. Spermidine is a precursor of Spermine. Spermidine is essential for both normal and neoplastic tissue growth.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Abraham, A.K., et al.: Eur. J. Biochem., 106, 257 (1980), Mach, M., et al.: Biochem. J., 202, 153 (1982), Thyss, A., et al.: Eur. J. Cancer Clin. Oncol., 18, 611 (1982),<br></p>

<p>Stability Hygroscopic<br>Applications Oleoyl-L-carnitine is a long-chain fatty ester of carnitine which is accumulated and released into the circulation, in fatty-acid oxidation defects. Pattern of Oleoyl-L-carnitine can be diagnostic for a number of ß-oxidation defects.<br>References Adams, S., et al.: J. Nutrition, 139, 1073 (2009); Ventura, F., et al.: Clinica Chimica Acta, 281, 1 (1999); Pourfarzam, M., et al.: Clinical Chem,, 40, 2267 (1994); Schaefer, J., et al.: Pediatric Res., 37, 354 (1995)<br></p>

<p>Applications N-Descarboxymethyl-N-carboxyethyl Lacosamide is an impurity of Lacosamide (L098500), an anticonvulsant drug that enhances sodium channel slow inactivation, and is used to treat patients with epilepsy.<br>References Doty, P., et al.: Neurotherapeutics, 4, 145 (2007); Perucca, E., et al.: Nat. Rev. Drug Discov., 7, 973 (2008); Sake, J., et al.: CNS Drugs, 24, 1055 (2010)<br></p>

<p>Applications N,N-Dimethylaminoethanol Phosphate is a metabolite of Dimethylaminoethanol, a precursor to the neurotransmitter acetylcholine.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Ansell, G.B. et al.: Zhur. Evol. Biochim, Fiziol., 15, 249 (1979): Miyazaki, H. et al.: Chem. Pharm. Bull., 24, 763 (1976); Haidar, N.E. et al.: Neurochem. Res., 19, 457 (1994);<br></p>

<p>Applications Tranexamic-d2 acid is deuterium labelled tranexamic acid (T714505), which is an antifibrinolytic agent that blocks lysine binding sites of plasminogen. Hemostatic.<br>References Andersson, et al.: Scand. J. Haematol. 2, 230 (1965), Melander, B., et al.: Acta Pharmacol. Toxicol., 22, 340 (1965), Bonnar, J., et al.: Br. Med. J., 313, 579 (1996), Dunn, C.J., et al.: Drugs, 57, 1005 (1999),<br></p>